VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $232,000 | -10.1% | 6,055 | -25.3% | 0.06% | -10.4% |
| Q4 2021 | $258,000 | +7.9% | 8,105 | 0.0% | 0.07% | +3.1% |
| Q3 2021 | $239,000 | -22.7% | 8,105 | -11.0% | 0.06% | -12.2% |
| Q2 2021 | $309,000 | +19.3% | 9,105 | +14.5% | 0.07% | +8.8% |
| Q1 2021 | $259,000 | +26.3% | 7,955 | +51.8% | 0.07% | +11.5% |
| Q3 2020 | $205,000 | -1.9% | 5,240 | -7.9% | 0.06% | -9.0% |
| Q2 2020 | $209,000 | – | 5,690 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |